About GLP Chart
Independent comparison site for US weight loss telehealth programs. We rank 25 programs against the same five criteria, re-check prices every Monday, and publish what we find. Nobody pays to be listed or to rank, and no program sees its review before it goes live.
Why this site exists
In 2024 GLP-1 prescribing through US telehealth went from a niche category to one of the fastest-growing consumer-healthcare markets in the country. Twenty-plus programs launched, each with its own pricing structure and lock-in terms, and its own idea of what “included” actually covers. Patients shopping cash-pay GLP-1 are forced to compare across formats that are deliberately incomparable. The comparison sites that existed at the time were either thinly disguised affiliate funnels that ranked whoever paid the highest commission, or were operated by the programs themselves under different brand names.
GLP Chart is the scoreboard. Every program in the chart is scored the same way against the same five criteria. We built it to be the independent GLP-1 comparison site the category was missing. We accept affiliate revenue, but the rank order is determined before we touch a partnership conversation. Programs do not see their score before we publish it. We do not change scores in response to partnership outreach.
Who runs this
Contact: hello@glpchart.com for general, press@glpchart.com for press and partnership. Press and business inquiries can also reach us on WhatsApp +1 (646) 305-3003.
How we score
Five dimensions, ten points each, weighted equally. The overall score is the simple average. The same scoring is applied to every program in the chart. The five dimensions:
Pricing transparency
- All costs published in advance
- Ongoing rates separated from introductory rates
- Lab and setup fees disclosed
Cancellation terms
- Lock-in periods scored on the same rubric
- Self-serve cancellation rewarded
- Phone-only cancellation flagged
- Non-refundable upfront fees called out
Onboarding experience
- Time from intake to first prescription
- Quality of clinical assessment
- Synchronous versus asynchronous visits
Medication options
- Branded availability
- Compounded availability
- Insurance pathway
- Dose flexibility
Member outcomes
- Verified-member feedback weighted above marketing copy
- We read Trustpilot, Reddit, and program-specific community feedback for every program
Full methodology, including how each dimension is operationalised: read the scoring methodology.
How we verify prices
Every price on the chart is checked against the program's published pricing pages, prices checked every Monday. We read the program's own pricing page for the maintenance-dose figure, not just the headline starter rate. When a program's site blocks automated access, we confirm the published number through a web search of the program's own materials. We do not create accounts, purchase medication or make any payment to gather these numbers. We cite the published source for every price so you can check it yourself.
See the quarterly Price Index for the per-program breakdown and the unit-cost (per milligram) analysis.
How we make money
We accept affiliate commissions on outbound clicks to partner programs. The commission does not affect scoring, rank order or editorial content. Programs are not told their score before publication. We don’t sell placement or sponsored content, and a program can’t pay to be in the chart.
If you are a reader: every “Visit” link in the chart that earns us a commission is labeled with rel="sponsored"for FTC compliance and Google's link policy. You can also see the full affiliate disclosure.
Medical review (actively recruiting)
GLP Chart is editorial, not medical. We do not dispense, prescribe or fulfill medications. Everything on the site is for educational purposes.
We are actively recruiting a credentialed medical reviewer (PA, NP, RN, PharmD or MD with obesity-medicine experience) to review every drug, program and clinical-content page. When that reviewer is in place, every applicable page will carry a “Medically reviewed by” strap naming the clinician and their credential. Until then, treat clinical claims on the site as sourced and cited but not personally verified by a licensed clinician.
- Scope: review and sign off on /drugs/, /program/, and clinical-content /learn/ pages. Roughly 4-8 hours per month after the initial onboarding pass.
- Compensation: monthly retainer (commensurate with credential level) plus optional equity in the LLC for the right candidate.
- What you get: a public byline on every page you review, a profile page on the site, and a hand in the editorial standards of the largest independent GLP-1 comparison site in the US.
- What we ask: active US licensure, no current employment relationship with any program in the chart, willingness to put your name and credentials on the work.
- Contact: hello@glpchart.com with your CV/CV-equivalent and a paragraph on your obesity-medicine experience.
Editorial disclosure
GLP Chart is an editorial comparison site. We are not a medical provider, telehealth platform, or pharmacy. Information on this site is for educational purposes only and is not medical advice. Consult a licensed healthcare professional before making any treatment decisions. When a program link is an affiliate link, we earn a commission if you sign up, at no cost to you. Updated June 5.
Some “Visit” links earn us a commission. Disclosure.
